Copyright Reports & Markets. All rights reserved.

Global Hydromorphone Hydrochloride Injection Market Research Report 2021

Buy now

1 Hydromorphone Hydrochloride Injection Market Overview

  • 1.1 Product Overview and Scope of Hydromorphone Hydrochloride Injection
  • 1.2 Hydromorphone Hydrochloride Injection Segment by Type
    • 1.2.1 Global Hydromorphone Hydrochloride Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 1mg/ml
    • 1.2.3 2mg/ml
    • 1.2.4 10mg/ml
  • 1.3 Hydromorphone Hydrochloride Injection Segment by Application
    • 1.3.1 Hydromorphone Hydrochloride Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Recovery Center
  • 1.4 Global Hydromorphone Hydrochloride Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Hydromorphone Hydrochloride Injection Revenue 2016-2027
    • 1.4.2 Global Hydromorphone Hydrochloride Injection Sales 2016-2027
    • 1.4.3 Hydromorphone Hydrochloride Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hydromorphone Hydrochloride Injection Market Competition by Manufacturers

  • 2.1 Global Hydromorphone Hydrochloride Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Hydromorphone Hydrochloride Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Hydromorphone Hydrochloride Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Hydromorphone Hydrochloride Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Hydromorphone Hydrochloride Injection Market Competitive Situation and Trends
    • 2.5.1 Hydromorphone Hydrochloride Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Hydromorphone Hydrochloride Injection Players Market Share by Revenue
    • 2.5.3 Global Hydromorphone Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hydromorphone Hydrochloride Injection Retrospective Market Scenario by Region

  • 3.1 Global Hydromorphone Hydrochloride Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Hydromorphone Hydrochloride Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Hydromorphone Hydrochloride Injection Market Facts & Figures by Country
    • 3.3.1 North America Hydromorphone Hydrochloride Injection Sales by Country
    • 3.3.2 North America Hydromorphone Hydrochloride Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Hydromorphone Hydrochloride Injection Market Facts & Figures by Country
    • 3.4.1 Europe Hydromorphone Hydrochloride Injection Sales by Country
    • 3.4.2 Europe Hydromorphone Hydrochloride Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Hydromorphone Hydrochloride Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Hydromorphone Hydrochloride Injection Sales by Region
    • 3.5.2 Asia Pacific Hydromorphone Hydrochloride Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Hydromorphone Hydrochloride Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Hydromorphone Hydrochloride Injection Sales by Country
    • 3.6.2 Latin America Hydromorphone Hydrochloride Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Hydromorphone Hydrochloride Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Hydromorphone Hydrochloride Injection Sales by Country
    • 3.7.2 Middle East and Africa Hydromorphone Hydrochloride Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Hydromorphone Hydrochloride Injection Historic Market Analysis by Type

  • 4.1 Global Hydromorphone Hydrochloride Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Hydromorphone Hydrochloride Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Hydromorphone Hydrochloride Injection Price by Type (2016-2021)

5 Global Hydromorphone Hydrochloride Injection Historic Market Analysis by Application

  • 5.1 Global Hydromorphone Hydrochloride Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Hydromorphone Hydrochloride Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Hydromorphone Hydrochloride Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Fresenius Kabi
    • 6.1.1 Fresenius Kabi Corporation Information
    • 6.1.2 Fresenius Kabi Description and Business Overview
    • 6.1.3 Fresenius Kabi Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Fresenius Kabi Product Portfolio
    • 6.1.5 Fresenius Kabi Recent Developments/Updates
  • 6.2 Hikma
    • 6.2.1 Hikma Corporation Information
    • 6.2.2 Hikma Description and Business Overview
    • 6.2.3 Hikma Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Hikma Product Portfolio
    • 6.2.5 Hikma Recent Developments/Updates
  • 6.3 Pfizer
    • 6.3.1 Pfizer Corporation Information
    • 6.3.2 Pfizer Description and Business Overview
    • 6.3.3 Pfizer Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pfizer Product Portfolio
    • 6.3.5 Pfizer Recent Developments/Updates
  • 6.4 Akorn
    • 6.4.1 Akorn Corporation Information
    • 6.4.2 Akorn Description and Business Overview
    • 6.4.3 Akorn Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Akorn Product Portfolio
    • 6.4.5 Akorn Recent Developments/Updates
  • 6.5 Teva
    • 6.5.1 Teva Corporation Information
    • 6.5.2 Teva Description and Business Overview
    • 6.5.3 Teva Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Teva Product Portfolio
    • 6.5.5 Teva Recent Developments/Updates
  • 6.6 Purdue
    • 6.6.1 Purdue Corporation Information
    • 6.6.2 Purdue Description and Business Overview
    • 6.6.3 Purdue Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Purdue Product Portfolio
    • 6.6.5 Purdue Recent Developments/Updates
  • 6.7 Sandoz
    • 6.6.1 Sandoz Corporation Information
    • 6.6.2 Sandoz Description and Business Overview
    • 6.6.3 Sandoz Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sandoz Product Portfolio
    • 6.7.5 Sandoz Recent Developments/Updates
  • 6.8 Baxter
    • 6.8.1 Baxter Corporation Information
    • 6.8.2 Baxter Description and Business Overview
    • 6.8.3 Baxter Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Baxter Product Portfolio
    • 6.8.5 Baxter Recent Developments/Updates
  • 6.9 Yichang Renfu Pharmaceutical
    • 6.9.1 Yichang Renfu Pharmaceutical Corporation Information
    • 6.9.2 Yichang Renfu Pharmaceutical Description and Business Overview
    • 6.9.3 Yichang Renfu Pharmaceutical Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Yichang Renfu Pharmaceutical Product Portfolio
    • 6.9.5 Yichang Renfu Pharmaceutical Recent Developments/Updates

7 Hydromorphone Hydrochloride Injection Manufacturing Cost Analysis

  • 7.1 Hydromorphone Hydrochloride Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Hydromorphone Hydrochloride Injection
  • 7.4 Hydromorphone Hydrochloride Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Hydromorphone Hydrochloride Injection Distributors List
  • 8.3 Hydromorphone Hydrochloride Injection Customers

9 Hydromorphone Hydrochloride Injection Market Dynamics

  • 9.1 Hydromorphone Hydrochloride Injection Industry Trends
  • 9.2 Hydromorphone Hydrochloride Injection Growth Drivers
  • 9.3 Hydromorphone Hydrochloride Injection Market Challenges
  • 9.4 Hydromorphone Hydrochloride Injection Market Restraints

10 Global Market Forecast

  • 10.1 Hydromorphone Hydrochloride Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Hydromorphone Hydrochloride Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Hydromorphone Hydrochloride Injection by Type (2022-2027)
  • 10.2 Hydromorphone Hydrochloride Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Hydromorphone Hydrochloride Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Hydromorphone Hydrochloride Injection by Application (2022-2027)
  • 10.3 Hydromorphone Hydrochloride Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Hydromorphone Hydrochloride Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Hydromorphone Hydrochloride Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    1mg/ml
    2mg/ml
    10mg/ml

    Segment by Application
    Hospital
    Clinics
    Recovery Center

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Fresenius Kabi
    Hikma
    Pfizer
    Akorn
    Teva
    Purdue
    Sandoz
    Baxter
    Yichang Renfu Pharmaceutical

    Buy now